← back to search

Timothy Wohlfromm

German Cancer Research Center · DE
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Diagnosis and Treatment, Head and Neck Cancer Studies, DNA Repair Mechanisms, and Epigenetics and DNA Methylation.
h-index
3
citations
65
works
7
NIH funding
primary concept
email

Recent publications

STIL overexpression shortens lifespan and reduces tumor formation in mice
PLoS Genetics 2024cited by 2position: middledoi
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
Nature Communications 2023cited by 31position: middledoi
Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary
Genes Chromosomes and Cancer 2022cited by 12position: middledoi
738P Combined ipilimumab and nivolumab in previously treated patients with cancer of unknown primary: Results of the CheCUP trial
Annals of Oncology 2022cited by 3position: middledoi
Local ablative treatment with surgery and/or radiotherapy in single-site and oligometastatic carcinoma of unknown primary
European Journal of Cancer 2021cited by 17position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bianca Kraft · German Cancer Research Center5 papers (2021–2024)Thomas Hielscher · German Cancer Research Center4 papers (2021–2023)Alwin Krämer · German Cancer Research Center4 papers (2021–2024)Tilmann Bochtler · Zentrum für Qualität in der Pflege4 papers (2021–2023)Maria Pouyiourou · German Cancer Research Center4 papers (2021–2023)Albrecht Stenzinger · Chirurgische Universitätsklinik Heidelberg3 papers (2021–2023)Stefan Delorme · German Cancer Research Center3 papers (2021–2023)H. Löffler · Danube Private University2 papers (2022–2023)Damian Stichel · German Cancer Research Center2 papers (2021–2022)Thomas Ernst · Comprehensive Cancer Center Mainfranken2 papers (2022–2023)Michael Ståhl · University Hospital Heidelberg2 papers (2022–2023)Andreas von Deimling · Stiftung Schleswig-Holsteinische Landesmuseen2 papers (2021–2022)Volker Endris · Deutschen Konsortium für Translationale Krebsforschung2 papers (2021–2022)Olaf Neumann · Heidelberg University2 papers (2021–2022)Katharina Brobeil · German Cancer Research Center1 papers (2024–2024) · 1 papers (2023–2023)Amira-Talaat Moussa · German Cancer Research Center1 papers (2024–2024) · 1 papers (2023–2023)Michael Bitzer · Friedrich Schiller University Jena1 papers (2023–2023)Karin Müller Decker · German Cancer Research Center1 papers (2024–2024)